Dr. Yanshuo Han is an Associate Professor and Head of the Molecular Medicine and Pharmacy Laboratory at the School of Chemical Engineering, Ocean Technology, and Life Science at Dalian University of Technology, China. Dr. Han completed his M.D. in Vascular Surgery at the Technische Universität München, Germany, following his master's and bachelor's degrees in General Surgery and Clinical Medicine from China Medical University.
Dr. Han's research field on vascular biology and vascular surgery, particularly the mechanisms of RNA methylation and epigenetic regulation in vascular diseases. His work extensively explores immune modulation, oxidative stress, and the development of novel therapies for abdominal aortic aneurysms and cardiovascular disorders. He has led and contributed to research projects funded by National Natural Science Foundation of China (NSFC), China Postdoctoral Science Foundation, Liaoning Provincial Natural Science Foundation of China, and Sino-German Center for Research Promotion.
As an active member of several academic societies, Dr. Han is Deputy Secretary-General, Medical Society of Western Returned Scholars Association, Vascular Surgery Branch and The Youth Committee of the Peripheral Disease Professional Committee of the China Microcirculation Society. He was employed as Middle-aged and Young Editorial board member of Cardiovascular Innovations and Applications, Chinese Journal of General Surgery, and Chinese Journal of Vascular Surgery.
As a leading expert in his field, Dr. Han has published 36 papers as the first or corresponding author, achieving an H-index of 17. His most cited works are published in high-impact journals such as European Journal of Vascular and Endovascular Surgery, Clinical Epigenetics, and International Journal of Biological Macromolecules, with the highest individual article impact factor reaching 12.5 (International Journal of Surgery).
He has been a guest editor and reviewer for prominent journals, including Frontiers in Genetics and Frontiers in Pharmacology.
His research contributions have significantly advanced understanding in vascular pathophysiology and epigenetic therapies.
